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The immune system provides organisms with robustness against pathogen threats, yet it also often
adversely affects the organism as in autoimmune diseases. Recently, the molecular interactions
involvedintheimmunesystemhavebeenuncovered.Atthesametime,theroleofthebacterialﬂora
and its interactions with the host immune system have been identiﬁed. In this article, we try to
reconcile these ﬁndings to drawa consistent picture of the host defense system. Speciﬁcally, weﬁrst
argue that the network of molecular interactions involved in immune functions has a bow-tie
architecture that entails inherent trade-offs among robustness, fragility, resource limitation, and
performance. Second, we discuss the possibility that commensal bacteria and the host immune
system constitute an integrated defense system. This symbiotic association has evolved to optimize
its robustness against pathogen attacks and nutrient perturbations by harboring a broad range of
microorganisms. Owing to the inherent propensity of a host immune system toward hyperactivity,
maintenance of bacterial ﬂora homeostasis might be particularly important in the development of
preventive strategies against immune disorders such as autoimmune diseases.
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Introduction
Defense against pathogens is one of the most important issues
for the survival of the organism. Such a function makes the
organism more robust against external threats. Robustness of
biological systems is gaining increasing attention these days
(Kitano, 2004; Stelling et al, 2004), and a conceptual frame-
work has been proposed that places robustness as one of the
fundamental properties of living organisms (Kitano, 2004).
As the immune system clearly provides robustness to the
organism, interpretation of its molecular interactions and
functions within the framework of biological robustness will
help us to better understand the immune system within an
integral framework of robust evolvable systems. It has been
argued that there are speciﬁc architectural characteristics in
robust evolvable systems, which are often denoted as a bow-
tie structure (Csete and Doyle, 2004), and several mechanistic
features such as systems control, fail–safe, modularity, and
decoupling (Kitano, 2004). It is also argued that systems that
are robust against speciﬁc perturbations are fragile against
unexpected perturbations (Carlson and Doyle, 2000, 2002;
Csete and Doyle, 2004). Aside from robustness fragility trade-
offs, enhancement in robustness results in increased demands
for resources and sacriﬁce of certain aspects of performance of
the system. If these are general properties of evolvable robust
systems,theimmunesystem,whichisanevolvablesubsystem
of the organism, is not an exception. Understanding such
features in the host protection system including the immune
system provides us with in-depth insights into the nature of
this system and how to cope with anomalies in the system.
Two aspects of the host protection system will be discussed
in this article: (1) the global architectural feature of the host
defensesystemanditsinherenttrade-offsbetweenrobustness,
fragility, resource limitation, and performance, and (2) the
symbiotic nature of the host–microbial relationship that
enhances the robustness of the host by adding a layer of
adaptive defense subsystem over the host immune system. In
fact, consideration of these two frameworks leads us to argue
that proper control and maintenance of the bacterial ﬂora are
essential to metazoan species by preventing and mitigating
autoimmune disorders.
In this article, we will ﬁrst describe the global molecular
interaction architecture of the immune system to illustrate its
characteristic bow-tie structure and inherent trade-offs.
Second, the relationship between bacterial ﬂora and the
host physiology will be discussed to demonstrate that the
commensal bacterial ﬂora is an integral part of the host
system. Then, we will present a series of medical implications
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Article number: 2006.0022deducedfromtheseobservations,andexaminetheimportance
of controlling commensal bacterial ﬂora for the prevention
of autoimmune disorders. Finally, we will speculate on the
characteristics of a possible bacterial ﬂora network.
The global molecular interaction
architecture of the immune system
and its inherent trade-offs
In order to provide defense against a variety of pathogens, the
immune system has to detect a broad range of molecular
signatures for pathogens and invoke effective countermea-
sures. It is clear that this has to be performed under resource-
limited conditions, because the number of cells for the immune
system and the number of molecules that can be involved in
immune reactions within each cell are not inﬁnite.
It is conceivable that such requirements imposed selective
pressure that has shaped the global architectural structure of
the immune system. A typical global architecture of a bow-tie
architecture comprises conserved and efﬁcient core processes
with diverse and redundant input and output processes (Csete
and Doyle, 2004; Kitano, 2004). We suggest here that the
molecular interactions of the immune system actually consist
of a nested tandem bow-tie architecture (Figure 1). This
architecture can be recognized both in intracellular signal
transduction pathways and in intercellular signaling pro-
cesses.The following examples will be considered: (i) Toll-like
receptor (TLR) signaling in innate immunity; (ii) processing
and recognition of MHC-peptides between antigen-presenting
cells (APCs) and T-cells; and (iii) convergence of signaling from
various cells into CD4þ T-cells to foster polarized prolifera-
tioninvolvingacomplexcytokinenetwork.Althoughthebow-
tie network is generally robust against attacks (i.e. removal of
network components) on its core (Li et al, 2004a), a central
part of the network connecting input and output networks,
the bow-tie network in the immune system at both intra-
cellular and intercellular levels is fragile against attacks on
non-redundant elements within its core. Removal of such an
element results in immunodeﬁciency, and confusions in mole-
cular pattern recognition in MHC-peptide–TCR interaction
lead to autoimmunity, both of which are manifestations of the
fragility of the bow-tie architecture in the immune system.
The TLR-mediated innate immune system has a bow-tie
architecture in which a wide variety of pathogens and
their molecules are represented by much smaller numbers
of ligands, called pathogen-associated molecular patterns
(PAMPs), recognized by11 TLRs (Akiraet al, 2001; Medzhitov,
2001; K Oda and H Kitano, in preparation) in mammalians.
Only a handful of adaptor proteins, including MyD88, MAL/
TIRAP, TRIF, and TRAM, and two primary kinases (TBK1
and IRAK) mediate the many responses from TLR activation.
MyD88 is a non-redundant core element of the main bow-tie
network. Stimulation of TLR signaling culminates with
massive transcriptional activation of a broad range of secreted
cytokines and chemokines (Beutler, 2004). Details of this
organization have been documented in a comprehensive
molecular interaction map of TLR signaling (K Oda and
H Kitano, in preparation). In addition to this bow-tie structure,
several positive and negative feedback loops exert important
regulatory actions. Thus, positive feedback loops involving
NF-kB play an important role in the dynamics of the immune
systeminboostingtheinnateimmuneresponse(LiandVerma,
2002) and possibly contributing to its propensity to become
hyperactivated.TLRsignalingnetworkisfragileagainstfailure
of the non-redundant core of this bow-tie structure, which
is MyD88. While there arecollateralpathwayssuch as MyD88-
independent pathway, MyD88 dominates the activation of
TLR-mediated responses. Collateral pathways such as MyD88-
independent pathways, small GTPase-mediated network, and
PIPs seem to modulate different responses to various stimuli
(K Oda and H Kitano, in preparation). Observation of
MyD88 knockout mice indicates that impeding one of these
hub proteins is fatal to the organism because it seriously
undermines the function of the innate immune system that
fails to detect pathogen-associated molecular signatures
(Adachi et al, 1998; Kawai et al, 1999; Csete and Doyle, 2004).
The adaptive immune subsystem displays a clear bow-tie
structure at both the cellular interaction and signal transduc-
tion levels. As shown in Figure 1A, signals triggered by
detection of potential threats are transmitted to naı ¨ve CD4þ
T-cells by APCs to stimulate their differentiation and cytokines
release. Upon recognition of an appropriate peptide–MHC
complexand/or cytokine stimuli, naı ¨ve CD4þ T-cells polarize
into either Th1, Th2, or Tr1 cells depending upon the
cytokine stimuli (Moser and Murphy, 2000; Luther and Cyster,
2001; Murphy and Reiner, 2002) that are provided by
polarized dendritic cell and a variety of innate immune cells
(Kapsenberg, 2003). Owing to the structure of the intercellular
interactions that form the bow-tie structure, with naı ¨ve CD4þ
T-cells as the core of the network, the system is vulnerable to
attack on CD4þ helper T-cells. AIDS is the result of an attack
on this fragility, as HIV selectively infects CD4þ helper T-cells
(McCune, 2001), eventually causing the entire immune system
to collapse and make the patient prone to opportunistic
infection (McCune, 2001).
At the signal transduction level, the most critical part of the
architecture of adaptive immunity is an MHC–TCR-centered
bow-tie network structure (Figure 1B). Various exogenous
materials are captured by APCs through phagocytosis, macro-
pinocytosis, and ﬂuid-phase endocytosis. APCs also express
a broad range of receptors that induce receptor-mediated
endocytosis. Captured exogenous materials undergo peptide
processing before being loaded onto MHC II and trimmed. The
size of loaded peptides on MHC II ranges between 13 and 17
(Rudensky et al, 1991), and only a core of peptides with a
length of about 9–10 amino acid epitope binds to a receptor on
CD4þ helper T-cells (Brown et al, 1993). A proper binding
of TCR to MHC II activates signal transduction pathways,
where adaptors such as LAT (a linker for activation of T-cells),
Srcfamily PTK, and ZAP-70 serve as critical mediators(Jordan
et al, 2003), triggering cytokine secretion and polarization.
MHC class I is yet another bow-tie structure where a wide
variety of peptides of endogenous origin and with a length
of 8–10 amino acids are processed for loading and trimming
on MHC I and are recognized by CD8þ T-cells (Yewdell and
Bennink, 2001) followed by various responses.
On the one hand, this architecture enhances the robustness
of the system by enabling it to cope efﬁciently with a broader
range of pathogens with limited resources. On the other hand,
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2 Molecular Systems Biology 2006 & 2006 EMBO and Nature Publishing GroupFigure 1 Nested bow-tie architecture in immune system. Salient features of the immune system network are nested bow-tie structures and extensive feedback loops.
(A) The bow-tie structure of intercellular interactions. The CD4þ T-cells are the hub of this interaction network. Various stimuli from pathogens are transmitted to
dendritic cells (DC) that polarize CD4þ T-cells. Stimuli trigger the differentiation of naı ¨ve CD4þ T-cells and effector cytokine releases to follow. The whole behavior of
this subsystem is controlled by complex signal transductions, and the cytokine network has adapted to the pathogenic environment to which it was exposed during
evolution.Uponrecognitionofappropriatepeptide–MHCcomplexand/orcytokinestimuli,naı ¨veCD4þ T-cellspolarizeintoeitherTh1,Th2,orTr1cellsdependingupon
thecytokinestimuli(MoserandMurphy,2000;LutherandCyster,2001;MurphyandReiner,2002)thatareprovidedbypolarizedDCandavarietyofinnateimmunecells
(Kapsenberg, 2003). Th1 cells are induced by IFN-g, IL-12, and IL-18, and secrete IFN-g and IL-2, whereas Th2 cells are induced by IL-4 and secrete IL-4, IL-5, IL-13,
andIL-10(Abbasetal,1996).ChromatinremodelingbyGATA3andT-betispivotalinTh1/Th2polarization(MurphyandReiner,2002).Effectorcytokinessecretedfrom
Th1and Th2cells affect various cells. Forexample, IFN-g activates B-cells to secrete IgG2a andIgG3, IL-2activates cytotoxic Tlymphocytes (CTL), andIL-4 andIFN-g
mutually inhibit the growth of Th1 and Th2 T-cells, respectively (Liew, 2002). Among these cytokines, IL-2 plays an important role in shaping the dynamics of T-cell
response because it promotes growth andactivation of CD4þ CD25þ regulatory T-cells (Horak et al, 1995), whichsuppress autoreactive T-cells whether Th1or Th2
(Shevach, 2002; Malek and Bayer, 2004). The source of IL-2 involved in CD4þ CD25þ T-cell activation has yet to be fully determined, but DC (Granucci et al, 2001)
and autoreactive T-cells (Malek and Bayer, 2004) are considered to be involved. CD4þ CD25þ regulatory T-cells are considered to interact with mature DC and
suppress helper and effector T-cell activities by an as yet unidentiﬁed mechanism (Mills, 2004). Th3 and Tr1 are induced by IL-4 in the presence of TGF-b and IL-10,
respectively (Weiner, 2001). Tr1 may also be induced by immature DC or IL-10-modulated DC under TGF-b stimulation (Mahnke et al, 2002; Kapsenberg, 2003).
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architecture is breached. Any confusion at the stage of MHC
presentation and TCR recognition results in systemic disorders
of the immune system. Thus, deﬁcient removal of cross-
reactiveT-cellsbyperipheraltolerancemechanismsmayresult
inautoimmunity.Theuseofrelativelyshortantigensequences
(less than 10 core amino acids) by the adaptive immune
system inevitably results in cases of molecular mimicry
when a presented antigen closely matches the host’s own
signature. Pathogens may trigger autoimmune responses if
Tr1 secretes IL-10 and TGF-b in a CTLA-4-dependent manner (Roncarolo et al, 2001) and Th3 secretes TGF-b. Repeated stimulation of naı ¨ve T-cells in the presence
of IL-10 induces Th1 T-cells, and a high dose of IL-10 suppresses the growth of both Th1 and Th2 cells (Read and Powrie, 2001). The mechanism of suppression of
CD4þ CD25þ T-cells is actively being investigated, but is considered to involve TGF-b release and binding of CTLA-4 to CD80 and CD86 on effector T-cells (von
Boehmer, 2005). The negative feedback loop is mediated by Tr1 and Th3, and CD4þ CD25þ regulatory T-cells constitute feedforward control via mature DC and
negative feedback control via autoreactive T-cells that are critical in the proper control of adaptive immune response to prevent autoimmune diseases. (B) The bow-tie
architecture also exists at the signal transduction level. There are bow-tie structures in the TLR signaling network and adaptive immunity where antigen presenting and
recognition is the hub of the network. APCs express a diverse range of receptors to recognize a wide variety of pathogens via PAMPs, etc. Signaling pathways and
capturing processes converge into a smaller variety of core processes. For TLRs, only a handful of adaptor proteins and kinases mediate the signaling process that
resultsindiverseresponsesincludingcytokinerelease,transcription,andotherevents.TheinnateimmunesystemcomprisesTLRsandtheirdownstream cascadesthat
form the characteristic shape of the network called a bow-tie, or hour-glass, structure (Csete and Doyle, 2004; Kitano, 2004). A wide variety of pathogens and their
moleculesarerepresentedbymuchsmallernumbersofligands,calledPAMPs,recognizedbyIL-1Rand10TLRs(Akiraetal,2001;Medzhitov,2001).Onlyahandfulof
adaptorproteins,such asMyD88, MAL/TIRAP,TRIF, andTRAM,andtwo primary kinases(TBK1and IRAK)mediatevarious responses and triggermassive changes in
a broad range of transcription of target genes including secretion of cytokines and chemokines (Beutler, 2004). MyD88 has special importance as it constitutes a non-
redundant core element of the main bow-tie network. Although there are collateral pathways such as MyD88-independent pathway, MyD88 is largely responsible for
activation of TLR-mediated responses. Collateral pathways play roles in modulating different responses. This is a versatile architecture that enables organisms to
evolutionarily add a new kind of receptor for new molecular signatures that eventually activate TBK1 and IRAK to bring about some responses. This is a bow-tie
architecture at the signaling pathway, and exists in a broad range of somatic cells, but most saliently in macrophage and DC. In this bow-tie structure, there are nested
bow-tie structures as well as positive feedback loops. For example, NF-kB and TNF form bow-tie structures having extensive input signals and changes in transcription
and cytokine production (Li and Verma, 2002). Positive feedback loops involving NF-kB play an important role in the dynamics of the immune system in boosting innate
immuneresponse.Anantigen-processingandpresentationprocesscapturesavarietyofpeptidesandpresentsthemonMHC-IorMHC-IImoleculesthatarerecognized
byTCRs.Thisantigenpresentationandrecognitionpartisacriticalcoreprocessinadaptiveimmunity.Abreachinproperpresentationandrecognitionleadstoimproper
immune reactions such as autoimmune diseases. Details of TLR signaling network are reported elsewhere (K Oda and H Kitano, in preparation).
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host tissue signatures. In fact, some autoimmune diseases are
now identiﬁed as being triggered by bacterial infection, such
as Crohn’s disease (CD) (Kobayashi et al, 2005; Maeda et al,
2005), which is an intestine autoimmune disease that causes
chronic inﬂammation. Dilated cardiomyopathy is associated
with cardiotropic virus infection triggering dendritic cell-
induced autoimmune heart failure (Eriksson et al, 2003). It
hasbeenarguedthatthebroadrangeofautoimmunedisorders
discussed above, as well as rheumatoid arthritis (RA),
systemic lupus erythematosus, and others, are due to multiple
exposuretopathogenicbacteriaandviruses(vonHerrathetal,
2003). This class of autoimmune diseases can be attributed to
breaches of theimmune response againstpathogens,bywhich
invaded pathogens trigger a sustained immune response by
molecular mimicry (Baum et al, 1996), possibly with TCR-
dependent bystander activation (von Herrath et al, 2003).
Theoretically, cross-activation via molecular mimicry
should have a signiﬁcantly lower rate if longer peptides are
presented to TCR. However, a signiﬁcantly large number of
T-cellsneedtobepreparedtoproperlyreacttoagreatervariety
of peptides presented. Otherwise, serious immunodeﬁciency
willtakeplace, asonlya fraction of peptides can be recognized
by the limited number of T-cells. Thus, MHC-peptide–TCR
recognition is constrained by trade-offs between robustness
against a broader range of pathogens, fragility against
misrecognition, and resource limitations of T-cells that can
be supplied.
Commensal bacterial ﬂora as an integral
part of the host defense system
Bacteria have been traditionally considered as ‘non-self’, and
thus subject to rejection by the immune system. However, the
fact is that certain species of bacteria successfully colonize our
body, and even provide us with essential functions without
which we could not survive. Commensal bacterial ﬂora are
ubiquitously observed in various metazoan species, including
termites (Schmitt-Wagner et al, 2003), cockroaches (Bracke
et al, 1979), prawns (Oxley et al, 2002), and mammalians,
and have established inseparable relationships with the
host organisms, and are even considered to have co-evolved
(Backhed et al, 2005). In human beings, the intestinal
microbiota contains 500–1000 species of diverse microorgan-
isms and about 10
14 bacteria, totaling about 1.5kg of biomass
(Xu and Gordon, 2003). It is breathtaking to realize that the
human as a symbiotic system consists of approximately
90%prokaryotesand10%eukaryotes(Savage,1977),andthat
a random shotgun sequencing of the whole human symbiotic
system would result in predominantly bacterial genome
readouts of about 2 million genes with sporadic mammalian
genes(Hooperetal,2002).Suchcommensalintestinalbacteria
play a critical role in various aspects of host physiology.
First,itisessentialforgutdevelopment.Germ-freemicethat
have no commensal bacterial ﬂora have an undeveloped
mucosal immune system that has hypoplastic Peyer’s patches,
as well as signiﬁcantly reduced numbers of IgA-producing
plasma cells and lamina propria CD4þ T-cells (Macpherson
et al, 2001, 2002). A recent study on one commensal
bacterial species, Bacteroides thetaiotaomicron, revealed
that it stimulates angiogenesis during postnatal intestine
development to enhance the nutrient-absorbing capability
(Stappenbeck et al, 2002).
Second, commensal bacteria even function antagonistically
against pathogenic bacteria, a phenomenon known as
colonization resistance. Continuous-ﬂow experiments using
asmallersubsetofcommensalbacteriarevealedthatthiseffect
is due to competition for nutrients and spaces that are
sustained by the dynamics of an intermicrobial metabolic
network (Ushijima and Ozaki, 1986, 1988). Perturbation of
commensal bacteria due to the use of antibiotics causes
antibiotic-associated diarrhea (Bergogne-Berezin, 2000) by
allowing pathogenic bacteria such as Clostridium difﬁcile to
proliferate. As yet another example, inﬂammatory bowel
diseases are considered to be caused by excessive activation
of the cell-mediated immune system to commensal enteric
bacteria (Sartor, 2003). This is perhaps due to reduced
biodiversity of the ﬂora, as indicated by a dramatic increase
in certain types of bacteria (Swidsinski et al, 2002).
Third, intestinal bacterial ﬂora contributes to the host’s
nutrient supply by, for example, contributing to starch
digestion, amino-acid homeostasis, and vitamin synthesis
(Hooper et al, 2002). Certain metabolic interactions are so
tightly coupled that metabolites are produced in which neither
host nor bacteria alone can produce (Nicholson and Wilson,
2003; Nicholson et al, 2005). As the composition of bacterial
ﬂora changes dynamically as a function of changes in the
dietary and nutrient contents (Harmsen et al, 2000; Mai and
Morris, 2004), it is essential for the host to be able to harbor
a broad range of bacteria to enable its ﬂora to cope with
environmental perturbations (Figure 2).
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Figure 2 Bacterial ﬂora biodiversity improves robustness against environ-
mental perturbations. (A) Upon changes in environmental conditions, such as
changes in types of foods and pathogens, the host that can accommodate highly
diverse bacterial ﬂora is able to cope with such changes by composition changes
ofbacterialﬂora.(B)Thehostthatonlyallowsanarrowsetofbacteria,hencelow
biodiversity bacterial ﬂora, may not be able to cope with changes in food
compositions and pathogens. This results in failure to digest certain types of
foods and invasion of pathogenic bacteria to the host tissues.
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host gene expression to establish mutually advantageous
partnerships (Hooperet al, 2001; Xu et al, 2003). Notonlydoes
the bacterial ﬂora affect the host, but the host’s genotype
(Zoetendal et al, 2001) and immunological responses (Hornef
et al, 2002) also reciprocally affect the activity and composi-
tion of the ﬂora. Therefore, the host immune system does not
ignore thebacterial ﬂora,but, rather, it maintains complexand
dynamic interactions with the commensal bacteria, which
results in a mutually beneﬁcial symbiotic state (Hornef et al,
2002). Owing to the intricate relationship between bacterial
ﬂora and the host, some believe that ﬂora should even be
considered as an ‘organ’, rather than an unwanted guest
(Hooper et al, 2002). The symbiotic association actually
provides enhanced robustness against environmental pertur-
bations by stimulating immune system development, nutrient
processing and biosynthesis, and resistance to pathogenic
microbes. These ﬁndings suggest that bacterial ﬂora are an
essentialpartofthesystem,andthattheimmunesystemmight
have co-evolved to allow diverse symbionts to reside on
the host without compromising the defense of the host against
pathogens. The fact that the defense system is a symbiotic
system implies that host defense functions are distributed
between the host system and the symbiont system, so
that perturbations of either one of these systems impedes
the overall function of the immune system. It is critically
important to obtain a better understanding of this
complex ecosystem in order to improve our understanding
of its relevance in disease outbreak, prevention, and
therapeutic control.
Medical implications
There are two theoretical frameworks that we must recognize
when discussing the medical implications of the arguments
developed so far. First, there is an inherent and inescapable
trade-off among robustness, resource limitations, perfor-
mance, and fragility of the system (Carlson and Doyle, 2000,
2002; Csete and Doyle, 2004; Kitano, 2004) that is exempliﬁed
in two typical problems of the immune system: (1) the trade-
offbetweentherobustnessrequiredtocopewithabroadrange
of pathogens and the limited resources available to the system
results in the riskof misrecognition due to short peptide length
for MHC presentation in adaptive immunity, and (2) breaches
of hubs within the bow-tie architecture render the mammalian
immune systems susceptible to attacks of CD4þ T-cells by
HIV or to mutations of MyD88. Second, if the commensal
bacterialﬂoraconstitutesanintegralpartofthehostprotection
system together with the host immune system, it is possible
that the perturbation of bacterial ﬂora homeostasis may
undermine the overall host defense immune function. It is
important to link these issues to illustrate a global perspec-
tive of the immune system because problems of host
immune systems, such as autoimmunity and fragility against
speciﬁc component failures, are deeply embedded within the
architectural feature of the immune system. In fact, these
observations indicate that maintenance of homeostasis of
commensal bacterial ﬂora and host immunity should be a
high-priority target for the prevention and mitigation of
immunological disorders.
In fact, there are increasing reports indicating a close
relationship between infections and pathogenesis and mitiga-
tion of immunological disorders (Bach, 2002, 2005), as well
as speciﬁc observations on bacterial ﬂora. For example,
a recent study revealed that the diversity of bacterial ﬂora in
CD patients and ulcerative colitis was reduced by 50 and
30% compared to the healthy control group, respectively,
and that such reduction of diversity was attributed to the loss
of normal anaerobic bacteria including Bacteroides species,
Eubacterium species, and Lactobacillus species (Ott et al,
2004). These bacteria that are signiﬁcantly lost in the popula-
tion are consistent with speciﬁc species that are observed
to have high intradivision biodiversity (Backhed et al,
2005), implying that this could disrupt the essential part of
the bacterial ﬂora network. An extensive concentration of
bacteria such as Mycobacterium paratuberculosis and
Listeria monocytogenes has been observed by biopsy of CD
patients using 16S rDNA PCR and DNA hybridization
analysis (Tiveljung et al, 1999). Combined with the genetic
susceptibility of the subpopulation of CD patients with
NOD2 mutation (Kobayashi et al, 2005; Maeda et al, 2005),
perturbations of bacterial ﬂora might have impeded the
ability of bacterial ﬂora to suppress such pathogenic bacteria
and allowed them to grow and invade. However, due to
the highly interactive nature of bacterial ﬂora and the
mucosal immune system, it is unclear whether such reduc-
tion in biodiversity of ﬂora is part of the cause or the result
of disease.
Nevertheless, enhancing the robustnessof bacterial ﬂorafor
disease prevention and cure may be a viable approach, as it is
tightly coupled with mucosal immune responses. One way to
accomplish this is to use probiotics to restore the balance of
commensals (Sartor, 2005; Sullivan and Nord, 2005). Promis-
ing results have been reported for refractory pouchitis, an
inﬂammation in the reservoirs, where clinical studies have
documented that chronic administration of VSL, a combina-
tion of four Lactorbacillus species, three Biﬁdobacterium
species, and Streptococcus salivarium subspecies, has been
effective in preventing relapse of refractory pouchitis (Gionch-
etti et al, 2000, 2003). For CD-related experiments, it has been
reportedthat production ofIL-10hasbeenfound tobeelevated
with the administration of VSL in vitro, and ex vivo treatment
of mucosal tissues from active CD patients shows reduced
TNF production with some Lactobacillus species (Sartor,
2003). However, the clinical outcome of probiotics treatment
of CD patients has had mixed results (Sartor, 2005). On the
contrary, control of bacterial ﬂora could be a more effective
means of prevention by mitigating the risk of invasion of
pathogenic bacteria by enhancing intestinal epithelial barrier
functions (Madsen et al, 2001) and suppressing the prolifera-
tion and attachment of pathogenic bacteria to the intestine
(Sartor, 2005).
Such approaches are worth pursuing, as current therapies
focus on suppression of immunological response by suppres-
sing TNF-a function, which was shown to be effective in
mitigating chronic inﬂammation and autoimmune diseases
including RA (Feldmann et al, 2004) and CD, but is associated
with the risk of side effects (Day, 2002; Feldmann and Maini,
2002). The effectiveness and risk of TNF-a target therapy are
predictable, as TNF-a is one of the major cytokine-activating
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innate immune responses, as well as a major component of
a positive feedback loop in cytokine networks activating TLR-
driven immune responses. However, the problem is that the
hyperactive immune response is caused by, at least in certain
subpopulations of patients, compromised immune response
(dueto reduced biodiversityof bacterial ﬂoraandmutations in
innate immune systems) followed by molecular mimicry.
Thus, TNF-a therapy leaves this root cause of the disease
untouched. With the discovery of TLRs, a range of therapies to
selectively inhibit TLRs have been proposed (Zuany-Amorim
et al, 2002). Although this provides us with a variety of
approaches to achieve higher levels of speciﬁcity, it is not
withoutsideeffects,becausethesetherapiesessentiallyreduce
the immune responses to a certain rangeof pathogenic targets.
Owing to the speciﬁcity of perturbations, side effects could
be less serious than TNF-a inhibitors, but they still undermine
normal immune functions. An even better approach for
neutralizing hyperactivity is to selectively mitigate the
inﬂammatory reaction itself without suppressing immune
reactions, but such work is still in the early stage (Nathan,
2002; Gilroy et al, 2004) and would not remedy the root cause.
If autoimmune responses are viewed as an inherent architec-
tural problem of the immune system, preventive strategies
might be more appropriate to successfully tackle the causes of
this class of immunological disorders. Therefore, approaches
to prevent and mitigate autoimmune disorders by controlling
biodiversity of bacterial ﬂora have the potential to provide
signiﬁcant beneﬁts for the health of patient and potential
patient populations.
The structure and dynamics of the
bacterial ﬂora network have to be
identiﬁed
Althoughbacterialﬂoraaffectsthepathogenesisandtreatment
of inﬂammatory diseases, the major problem is that the
complexity and dynamics of bacterial ﬂora and their inter-
action with pathogens and the mucosal immune system are
largely unknown. Unexpected and counterintuitive dynamics
often associated with complex networks may be a cause of the
mixed results.
First, the composition of microorganisms constituting
bacterial ﬂora has yet to be identiﬁed. It was only in the last
5 years that genomic analysis using cloned 16S rRNA gene
(rDNA) sequences has become available to identify the
composition of bacteria for the signiﬁcant number of bacterial
species that cannot be cultured (Suau et al, 1999). Although
enormous biodiversity involving over 500–1000 species is
well accepted, a recent study revealed the existence of
extremely dense biodiversity within selected divisions such
asCytophage–Flavobacterium–BacteroidesandtheFirmicutes
(Backhed et al, 2005). This implies a highly redundant
network that ensures robustness upon reduction of biodiver-
sity, as postulated by the insurance hypothesis (Yachi and
Loreau, 1999).
Second,thekindsofinteractionnetworksthatbacterialﬂora
form have not yet been identiﬁed. Although it is understood
that diverse species of bacteria constitute bacterial ﬂora and
that they interact by exchanging metabolic products and
nutrients as well as competing for space and resources, the
structure of the networks that such interactions generate is
largely unknown. Furthermore, interactions are taking place
not only among bacteria, but also between bacteria and host
tissues. Depending upon the structure of the network, its
dynamics can be dramatically different (Li et al, 2004b). There
are some cues that enable us to speculate on the possible
network structures. First, a partial proﬁle of the diversity of
bacteria composition has recently been revealed, as discussed
above. Second, there is resource competition between
bacterial species over nutrition and spaces. Substances that
are preferredfor metabolism by a broader rangeof bacteria are
quickly consumed, precluding limitless growth of interactions
over such substances; hence preferential attachment essential
for a scale-free network (Barabasi and Oltvai, 2004) may not
take place. In fact, the food web that also involves resource
competition and metabolic ﬂow was shown to be neither
a random network nor a small-world scale-free network
(Dunne et al, 2002). Third, pressure exists for optimization
of the bacterial ﬂora network toward its stable functioning.
The metabolic network of bacterial ﬂora has to efﬁciently
digest incoming substances and convert them into a form
suitable for absorption by the gut, synthesize nutrients that
cannot be produced by the host alone, and resist invasion by
pathogenic microbes. Failure to accomplish such tasks may
cause inﬂammation and diarrhea that impede growth of the
bacterial ﬂora. This implies that only bacterial ﬂora networks
that are optimized, or suboptimized, for certain functions
can persist, whereas networks that fail to function properly
will be impeded and reconstructed.
Although it is not possible to infer the possible structure
conclusively, it is often the case that the global structure of
a network that is being optimized, whether by evolution or
bydesign, entails highly optimized tolerance (HOT) properties
(Carlson and Doyle, 2000, 2002; Li et al, 2004a) and takes
a bow-tie structure (Csete and Doyle, 2004; Kitano, 2004) in
which a highly conserved and robust core network ensures
efﬁcient processing of diverse inputs and generation of diverse
outputs. Such a network structure is also observed in bacterial
metabolic networks (Ma and Zeng, 2003; Tanaka, 2005).In the
bacterial ﬂora network, highly redundant clusters of species
and strains under selected divisions form a conserved robust
core network, and diverse bacterial species interface with this
core network. In this regard, the bacterial ﬂora network may
resemble a bow-tie structure, but is also affected by competi-
tion among bacterial species and the nature of pressures
imposed. If the network actually has a bow-tie structure, the
metabolic network of bacterial ﬂora and host tissue can be
highlyrobustagainsteliminationofbacterialspecies.Thisisin
contrast to the scale-free network, where selective removal
of hubs signiﬁcantly degrades its performance. In addition,
a bow-tie metabolic network shall be highly efﬁcient, whereas
the scale-free network may suffer from the bottleneck of a hub
node capacity. The excessive use of antibiotics impedes
bacterial ﬂora regardless of network topology as their effects
arenonspeciﬁcandeliminatesasigniﬁcantportionofbacterial
ﬂora. Although bow-tie networks with HOT properties are
robust, efﬁcient, and scale rich, they can be fragile when
speciﬁc pathogenic bacterial species take over the ﬂora, while
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molecular interactions to fake non-pathogenic bacteria
(Li et al, 2004a).
Conclusion
Our assumption in this article is that commensal bacterial
ﬂora and the immune system create a state of symbiosis that
effectively provides host defense against various pathogens,
and that the involvement of commensal bacterial ﬂora is
pivotal to better accomplish this function through potential
adaptability to environmental changes, thus increasing the
robustness of the host–symbiont system.
This notation may have an interesting implication for the
function of the immune system, namely, what is the immune
system optimized for? The logical consequence of our
assumption is that the immune system is optimized to provide
robustness to the host–symbiont system, instead of providing
defense to the host organism alone, against a variety of
pathogenic threats from the environment. This means that
the immune system enhances the robustness of the organisms
by enabling them to harbor a broader range of symbionts, yet
rejecting pathogenic microorganisms. The premise of this
hypothesis is that harboring a broader range of symbionts
increases the robustness of the host organism by enabling
a spectrum of adaptive responses against changes in
dietary and nutrient contents and exposure to pathogenic
microorganisms.
Owingtoinherenttrade-offsofthehostimmune system,itis
critically important that bacterial ﬂorahomeostasis is properly
maintained to prevent and mitigate immunological disorders.
Although there have been sporadic reports on the possible
impacts of controlling bacterial ﬂora to counter autoimmune
diseases and allergies, no convincing result has yet been
reported.Thisisperhapsowingtoourlackofunderstandingof
this highly complex ecosystem of bacterial ﬂora that also
interacts with the host and the environment. The future lies in
a better understanding of this biological continuum of the
internal and external ecosystems. Interestingly, recent devel-
opmentsinmetagenome(orsystemsecology)research(Venter
et al, 2004; Delong, 2005) may provide us with tools and
concepts to answer the question.
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